NCT00279890

Topical Agent for Treatment of Red Skin

Proof of Concept Trial:SR-01 for the Treatment of Rosacea

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 20 (planned)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

SR-01 may reduce facial redness. it is a topically applied product. The agent will be applied to local skin areas of subjects with red facial skin to assess affect, and then applied to the whole face to assess efficacy and safety

Conditions

• Rosacea
• Bilaterally Symmetric Red Skin on Cheeks

Interventions

Type	Name	Description
DRUG	Topical SR-01

Timeline

• Start date: 2005-07-01
• Primary completion: 2007-01-01
• Completion: 2007-01-01
• First posted: 2006-01-20
• Last updated: 2011-05-23

Locations

1 site across 1 country: United States